The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04919642
Recruitment Status : Completed
First Posted : June 9, 2021
Last Update Posted : April 26, 2024
Information provided by (Responsible Party):
TransThera Sciences (Nanjing), Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 28, 2024
Actual Study Completion Date : February 28, 2024